{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T22:48:59Z","timestamp":1794005339217,"version":"4.8.0"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100007219","name":"Natural Science Foundation of Shanghai Municipality","doi-asserted-by":"publisher","award":["23ZR1414200"],"award-info":[{"award-number":["23ZR1414200"]}],"id":[{"id":"10.13039\/100007219","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005693","name":"Hainan University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005693","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003347","name":"Fudan University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003347","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003399","name":"Science and Technology Commission of Shanghai Municipality","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003399","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.ejmech.2025.117857","type":"journal-article","created":{"date-parts":[[2025,6,9]],"date-time":"2025-06-09T19:10:47Z","timestamp":1749496247000},"page":"117857","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Novel trimethyl lock-based prostate-specific membrane antigen targeted Conjugates: Design, synthesis, and biological activity evaluation"],"prefix":"10.1016","volume":"296","author":[{"given":"Jiangzhu","family":"Zhan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijun","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuaibing","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4684-2911","authenticated-orcid":false,"given":"Wei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2023","key":"10.1016\/j.ejmech.2025.117857_bib1","first-page":"191","article-title":"Update on prostate cancer epidemiology and risk Factors-A systematic review","volume":"84","author":"Bergengren","year":"2022","journal-title":"Eur. Urol."},{"issue":"2022","key":"10.1016\/j.ejmech.2025.117857_bib2","first-page":"7","article-title":"Cancer statistics","volume":"72","author":"Siegel","year":"2022","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.ejmech.2025.117857_bib3","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1097\/MOU.0000000000000951","article-title":"Why do African-American men face higher risks for lethal prostate cancer?","volume":"32","author":"Nair","year":"2022","journal-title":"Curr. Opin. Urol."},{"key":"10.1016\/j.ejmech.2025.117857_bib4","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.urology.2019.09.058","article-title":"Health care disparities in urologic oncology: a systematic review","volume":"136","author":"Das","year":"2020","journal-title":"Urol. Times"},{"key":"10.1016\/j.ejmech.2025.117857_bib5","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1158\/1078-0432.CCR-15-0820","article-title":"New strategies in prostate cancer: prostate-specific membrane antigen (PSMA) ligands for diagnosis and therapy","volume":"22","author":"Haberkorn","year":"2016","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ejmech.2025.117857_bib6","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/s41391-021-00394-5","article-title":"Advances in PSMA-targeted therapy for prostate cancer","volume":"25","author":"Wang","year":"2022","journal-title":"Prostate Cancer Prostatic Dis."},{"key":"10.1016\/j.ejmech.2025.117857_bib7","first-page":"63","article-title":"Toward the discovery and development of PSMA targeted inhibitors for nuclear medicine applications","volume":"13","author":"Pastorino","year":"2020","journal-title":"Curr. Rad."},{"key":"10.1016\/j.ejmech.2025.117857_bib8","doi-asserted-by":"crossref","DOI":"10.3390\/ph16020315","article-title":"PSMA-targeted nanotheranostics for imaging and radiotherapy of prostate cancer","volume":"16","author":"Meher","year":"2023","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.ejmech.2025.117857_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2023.106889","article-title":"Advances in non-radioactive PSMA-targeted small molecule-drug conjugates in the treatment of prostate cancer","volume":"141","author":"Chen","year":"2023","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2025.117857_bib10","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/j.jconrel.2020.10.023","article-title":"PSMA-targeted nanoparticles for specific penetration of blood-brain tumor barrier and combined therapy of brain metastases","volume":"329","author":"Ni","year":"2021","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.ejmech.2025.117857_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.117125","article-title":"PSMA-targeted combination brusatol and docetaxel nanotherapeutics for the treatment of prostate cancer","volume":"177","author":"Adekiya","year":"2024","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ejmech.2025.117857_bib12","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1080\/10837450.2021.1875238","article-title":"Glutamate-urea-based PSMA-targeted PLGA nanoparticles for prostate cancer delivery of docetaxel","volume":"26","author":"Saniee","year":"2021","journal-title":"Pharmaceut. Dev. Technol."},{"key":"10.1016\/j.ejmech.2025.117857_bib13","doi-asserted-by":"crossref","first-page":"7921","DOI":"10.7150\/thno.49577","article-title":"The EPR effect and beyond: strategies to improve tumor targeting and cancer nanomedicine treatment efficacy","volume":"10","author":"Shi","year":"2020","journal-title":"Theranostics"},{"key":"10.1016\/j.ejmech.2025.117857_bib14","article-title":"PSMA-targeted supramolecular nanoparticles prepared from Cucurbit[8]uril-Based ternary host-guest recognition for prostate cancer therapy","volume":"10","author":"Zhang","year":"2022","journal-title":"Front. Chem."},{"key":"10.1016\/j.ejmech.2025.117857_bib15","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202304618","article-title":"Prostate-specific membrane antigen targeted StarPEG nanocarrier for imaging and therapy of prostate cancer","volume":"13","author":"Meher","year":"2024","journal-title":"Adv. Healthcare Mater."},{"key":"10.1016\/j.ejmech.2025.117857_bib16","doi-asserted-by":"crossref","DOI":"10.3390\/biom9090421","article-title":"Tumor uptake of triazine dendrimers decorated with four, sixteen, and sixty-four PSMA-targeted ligands: passive versus active tumor targeting","volume":"9","author":"Lim","year":"2019","journal-title":"Biomolecules"},{"key":"10.1016\/j.ejmech.2025.117857_bib17","doi-asserted-by":"crossref","first-page":"17405","DOI":"10.1021\/acsnano.0c07610","article-title":"Bioengineered human serum albumin fusion protein as target\/enzyme\/PH three-stage propulsive drug vehicle for tumor therapy","volume":"14","author":"Wang","year":"2020","journal-title":"ACS Nano"},{"key":"10.1016\/j.ejmech.2025.117857_bib18","doi-asserted-by":"crossref","first-page":"385","DOI":"10.3109\/10837450.2014.882940","article-title":"PLGA micro and nanoparticles in delivery of peptides and proteins; problems and approaches","volume":"20","author":"Mohammadi-Samani","year":"2015","journal-title":"Pharmaceut. Dev. Technol."},{"key":"10.1016\/j.ejmech.2025.117857_bib19","doi-asserted-by":"crossref","first-page":"14693","DOI":"10.1021\/acsnano.2c05341","article-title":"Hypoxia-activated PEGylated paclitaxel prodrug nanoparticles for potentiated chemotherapy","volume":"16","author":"Hao","year":"2022","journal-title":"ACS Nano"},{"key":"10.1016\/j.ejmech.2025.117857_bib20","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/0005-2728(69)90135-2","article-title":"The conservation of oxidative energy in phosphate-free systems. Formation of acyl anhydrides via the oxidation of hydroquinone monocarboxylic esters","volume":"172","author":"Thanassi","year":"1969","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ejmech.2025.117857_bib21","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1073\/pnas.67.3.1143","article-title":"Rate acceleration by stereopopulation control: models for enzyme action","volume":"67","author":"Milstien","year":"1970","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ejmech.2025.117857_bib22","doi-asserted-by":"crossref","first-page":"9158","DOI":"10.1021\/ja00781a029","article-title":"Rate enhancement in the lactonizations of 0-hydroxyhydrocinnamic acids","volume":"94","author":"Milstien","year":"1972","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.ejmech.2025.117857_bib23","doi-asserted-by":"crossref","first-page":"2412","DOI":"10.1039\/c2sc20536j","article-title":"Trimethyl lock: a trigger for molecular release in chemistry, biology, and pharmacology","volume":"3","author":"Levine","year":"2012","journal-title":"Chem. Sci."},{"key":"10.1016\/j.ejmech.2025.117857_bib24","article-title":"Trimethyl lock based tools for drug delivery and cell imaging - synthesis and properties","volume":"31","author":"Skwarecki","year":"2025","journal-title":"Chemistry"},{"key":"10.1016\/j.ejmech.2025.117857_bib25","doi-asserted-by":"crossref","DOI":"10.1002\/cbic.201800269","article-title":"Trimethyl lock: a multifunctional molecular tool for drug delivery, cellular imaging, and stimuli-responsive materials","author":"Okoh","year":"2018","journal-title":"Chembiochem"},{"key":"10.1016\/j.ejmech.2025.117857_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.tetlet.2022.153989","article-title":"Development of camptothecin nano-prodrugs based on trimethyl lock groups toward selective drug release in cancer cells","volume":"103","author":"Shibata","year":"2022","journal-title":"Tetrahedron Lett."},{"key":"10.1016\/j.ejmech.2025.117857_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2022.106228","article-title":"Structure-activity relationship study of a series of nucleoside derivatives bearing sulfonamide scaffold as potent and selective PRMT5 inhibitors","volume":"130","author":"Chen","year":"2023","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2025.117857_bib28","doi-asserted-by":"crossref","first-page":"15593","DOI":"10.1021\/acs.jmedchem.1c00419","article-title":"Development of a redox-sensitive spermine prodrug for the potential treatment of snyder robinson syndrome","volume":"64","author":"Tantak","year":"2021","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117857_bib29","doi-asserted-by":"crossref","DOI":"10.3390\/biom11091357","article-title":"Esterase-sensitive prodrugs of a potent bisubstrate inhibitor of nicotinamide N-Methyltransferase (NNMT) display cellular activity","volume":"11","author":"van Haren","year":"2021","journal-title":"Biomolecules"},{"key":"10.1016\/j.ejmech.2025.117857_bib30","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1021\/jacs.7b09795","article-title":"Toward direct protein S-Persulfidation: a prodrug approach that directly delivers hydrogen persulfide","volume":"140","author":"Yu","year":"2018","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.ejmech.2025.117857_bib31","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1021\/acs.bioconjchem.6b00222","article-title":"Design of a small-molecule drug conjugate for prostate cancer targeted theranostics","volume":"27","author":"Kumar","year":"2016","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.ejmech.2025.117857_bib32","doi-asserted-by":"crossref","first-page":"5784","DOI":"10.3390\/molecules25245784","article-title":"Polypeptide-based molecular platform and its Docetaxel\/Sulfo-Cy5-Containing conjugate for targeted delivery to prostate specific membrane antigen","volume":"25","author":"Petrov","year":"2020","journal-title":"Molecules (Basel)"},{"key":"10.1016\/j.ejmech.2025.117857_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.120822","article-title":"Docetaxel encapsulation in nanoscale assembly micelles of folate-PEG-docetaxel conjugates for targeted fighting against metastatic breast cancer in vitro and in vivo","volume":"605","author":"Andisheh","year":"2021","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejmech.2025.117857_bib34","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1021\/bm500246w","article-title":"PEG\u2013peptide conjugates","volume":"15","author":"Hamley","year":"2014","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.ejmech.2025.117857_bib35","doi-asserted-by":"crossref","first-page":"5722","DOI":"10.1016\/j.biomaterials.2013.04.012","article-title":"Linear-dendritic drug conjugates forming long-circulating nanorods for cancer-drug delivery","volume":"34","author":"Zhou","year":"2013","journal-title":"Biomaterials"},{"key":"10.1016\/j.ejmech.2025.117857_bib36","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/anie.201105735","article-title":"A general strategy to construct fluorogenic probes from charge-generation polymers (CGPs) and AIE-active fluorogens through triggered complexation","volume":"51","author":"Li","year":"2012","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.ejmech.2025.117857_bib37","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.biomaterials.2018.10.036","article-title":"Dual responsive micelles capable of modulating miRNA-34a to combat taxane resistance in prostate cancer","volume":"192","author":"Lin","year":"2019","journal-title":"Biomaterials"},{"key":"10.1016\/j.ejmech.2025.117857_bib38","doi-asserted-by":"crossref","first-page":"4618","DOI":"10.1002\/jcp.29339","article-title":"PEG-PLA nanoparticles decorated with small-molecule PSMA ligand for targeted delivery of galbanic acid and docetaxel to prostate cancer cells","volume":"235","author":"Afsharzadeh","year":"2020","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.ejmech.2025.117857_bib39","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0112200","article-title":"PSMA ligand conjugated PCL-PEG polymeric micelles targeted to prostate cancer cells","volume":"9","author":"Jin","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.ejmech.2025.117857_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113936","article-title":"PSMA-targeted small-molecule docetaxel conjugate: synthesis and preclinical evaluation","volume":"227","author":"Machulkin","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117857_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2024.117753","article-title":"Design, synthesis and evaluation of novel prostate-specific membrane antigen-targeted aryl [18F]fluorosulfate PET tracers","volume":"106","author":"Wang","year":"2024","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117857_bib42","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1021\/acs.molpharmaceut.8b00026","article-title":"Prostate-specific membrane antigen targeted therapy of prostate cancer using a DUPA\u2013paclitaxel conjugate","volume":"15","author":"Lv","year":"2018","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejmech.2025.117857_bib43","doi-asserted-by":"crossref","first-page":"3303","DOI":"10.1021\/jo00275a012","article-title":"Reductive lactonization of strategically methylated quinone propionic acid esters and amides","volume":"54","author":"Carpino","year":"1989","journal-title":"J. Org. Chem."},{"key":"10.1016\/j.ejmech.2025.117857_bib44","doi-asserted-by":"crossref","first-page":"14133","DOI":"10.1002\/chem.201703087","article-title":"Efficient One-Pot Multifunctionalization of Alkynes en Route to \u03b1-Alkoxyketones, \u03b1-Thioketones, and \u03b1-Thio Thioketals by using an Umpolung Strategy","volume":"23","author":"Xu","year":"2017","journal-title":"Chemistry"},{"key":"10.1016\/j.ejmech.2025.117857_bib45","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1021\/acschembio.5b00966","article-title":"Boronic acid for the traceless delivery of proteins into cells","volume":"11","author":"Andersen","year":"2016","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.ejmech.2025.117857_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.116071","article-title":"Design, synthesis and biological evaluation of carbamate derivatives incorporating multifunctional carrier scaffolds as pseudo-irreversible cholinesterase inhibitors for the treatment of alzheimer's disease","volume":"265","author":"Liu","year":"2024","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117857_bib47","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1002\/pi.5892","article-title":"PEGylated polylysine derived copolymers with reduction-responsive side chains for anticancer drug delivery","volume":"68","author":"Yao","year":"2019","journal-title":"Polym. Int."},{"key":"10.1016\/j.ejmech.2025.117857_bib48","doi-asserted-by":"crossref","first-page":"3050","DOI":"10.1055\/s-0035-1561637","article-title":"A divergent approach for the synthesis of d- and l-4\u2032-Ethynyl dioxolane nucleosides with potent Anti-HIV activity","volume":"48","author":"Singh","year":"2016","journal-title":"Synthesis"},{"key":"10.1016\/j.ejmech.2025.117857_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2022.121940","article-title":"Anti-adhesive bioresorbable elastomer-coated composite hernia mesh that reduce intraperitoneal adhesions","volume":"292","author":"Nikam","year":"2023","journal-title":"Biomaterials"},{"key":"10.1016\/j.ejmech.2025.117857_bib50","series-title":"Tollnine","article-title":"Immunomodulating polynucleotide conjugates and methods of use in cancer immunotherapy","author":"Pons","year":"2020"},{"key":"10.1016\/j.ejmech.2025.117857_bib51","doi-asserted-by":"crossref","first-page":"7064","DOI":"10.1039\/c3tc31588f","article-title":"Cross-linking of discotic tetraazaporphyrin dyes in 2 and 3 dimensions by \u201cclick\u201d chemistry","volume":"1","author":"Kayal","year":"2013","journal-title":"J. Mater. Chem. C"},{"key":"10.1016\/j.ejmech.2025.117857_bib52","doi-asserted-by":"crossref","first-page":"317","DOI":"10.5155\/eurjchem.9.4.317-321.1729","article-title":"A mild and efficient method for the deprotection of trimethyl silyl alkynes using sodium ascorbate and copper sulphate","volume":"9","author":"Siddaraj","year":"2018","journal-title":"Eur. J. Chem."},{"key":"10.1016\/j.ejmech.2025.117857_bib53","first-page":"916","volume":"34","author":"Ren","year":"2020"}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523425006221?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523425006221?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,8,12]],"date-time":"2025-08-12T08:39:36Z","timestamp":1754987976000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523425006221"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":53,"alternative-id":["S0223523425006221"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2025.117857","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Novel trimethyl lock-based prostate-specific membrane antigen targeted Conjugates: Design, synthesis, and biological activity evaluation","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2025.117857","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"117857"}}